Fractyl Health, Inc.
GUTSNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $169.75M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.38$12.24
- Volume (live)
- -
- Avg. volume (3M)
- 776.58K
Fractyl Health (GUTS) Stock Price & Financial Analysis
Fractyl Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.02 - $1.12 |
|---|---|
| 52-Week High | $12.24 |
| 52-Week Low | $0.38 |
| Open | $1.08 |
| Volume (last close) | 363.04K |
| Average Volume (3M) | 776.58K |
| 50-Day MA | $6.61 |
|---|---|
| 200-Day MA | $3.28 |
| 1-Year Change | −18.12% |
| Market Cap | 169.75M |
|---|---|
| Shares Outstanding | 158.65M |
| Price to Book (P/B) | -101.95 |
| EV/EBITDA | -3.07 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Fractyl Health at a Glance
As of the Oct 26, 2026 close, Fractyl Health (GUTS) has a market capitalization of $169.75M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $47.14M in cash and securities against $35.63M of debt, a net cash position of $11.51M.
Fractyl Health does not currently pay a dividend.
The share price is down 18.1% over the past year. At $1.07 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $0.38 to $12.24, below its 200-day moving average of $3.28.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $16.00, 1395.3% above the Oct 26, 2026 close.
Frequently Asked Questions About Fractyl Health
What is the current stock price for GUTS?
As of the Oct 26, 2026 close, GUTS stock trades at $1.07. The 52-week range is $0.38–$12.24, with a day range of $1.02–$1.12.
What is the P/E ratio for GUTS?
The P/E ratio (Price-to-Earnings) for GUTS is shown in the Key Statistics section. This valuation metric helps compare Fractyl Health, Inc. to industry peers.
Does GUTS pay dividends?
Fractyl Health does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GUTS?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for GUTS is Buy. The average 12-month price target is $16.00, a 1395.3% upside from the Oct 26, 2026 close of $1.07.
What is the market cap of GUTS?
As of the Oct 26, 2026 close, Fractyl Health's market capitalization is $169.8M, classifying it as a micro-cap company. Fractyl Health operates in the Healthcare sector within the Biotechnology industry.